Sonoma Pharmaceuticals (SNOA) Tops Q3 EPS by 6c

Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q3 EPS of ($0.63), $0.06 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $4 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.

You May Also Be Interested In

• Reports Of Blasts Across Iran's Southern Regions: State TV - Bloomberg
• Can-Am to provide $150,000 and vehicles to Farm Rescue over three years
• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line